Floatz logo

Daunorubicin

Testicular Leukemia

Children's Oncology GroupPhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Testicular Leukemia cohort.

Asset / SponsorPhaseRating
MERCAPTOPURINE ANHYDROUS
Children's Oncology Group
Phase 3BB
THIOGUANINE ANHYDROUS
Children's Oncology Group
Phase 3BB
VINCRISTINE SULFATE
Children's Oncology Group
Phase 3BB
Cytosin-Arabinosid
Children's Oncology Group
Phase 3BB
PREDNISONE TABLETS
Children's Oncology Group
Phase 3BB

View all 18 →

Same molecule, other indications

Daunorubicin is also rated in:

acute myeloid leukemia by FAB classificationDormant
BBB
Indicative ·
78 / 100
View asset →
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
77 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →